Evidence map›Paper›PMID 17989713›Full record

ArticleLeukemia2008

The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma.

E D Remstein, M Law, M Mollejo, M A Piris, P J Kurtin, A Dogan

Open access · greenAbstract readLetter
In one paragraph

Article in Leukemia, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Observational
  6. [Advances in molecular genetics pathogenesis of splenic marginal zone lymphoma].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2016
    Article
  7. Article
  8. PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2010
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2008
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

E D Remstein
M Law
M Mollejo
M A Piris
P J Kurtin
A Dogan
Mayo Clinic · USMayo Clinic in Arizona · USHospital Virgen de la Salud · ESSpanish National Cancer Research Centre · ES

Funding

The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI WEINER, GEORGE J. · 2002 to 2021
$45.7M
NCI NIH HHS CA97274NCI NIH HHS P50 CA097274
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gene DeletionTranslocation, GeneticChromosomes, Human, Pair 7HumansImmunoglobulin GIn Situ Hybridization, FluorescenceLymphoma, B-Cell, Marginal ZonePrognosisSplenic NeoplasmsImmunoglobulin G

Identifiers

PMID17989713
PMCPMC12038708
OpenAlexW1982365706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.